Activity of posaconazole in the treatment of central nervous system fungal infections.

<h4>Objectives</h4>A multinational, multicentre, open-label clinical trial was conducted to evaluate the safety and efficacy of posaconazole, an extended-spectrum triazole antifungal agent, in subjects with invasive fungal infections who had refractory disease or who were intolerant of standard anti... View More